Device Trial Radar · NCT01787227
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
Last checked: Nov 20, 2026Latest source record: Mar 3, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Luminex Molecular DiagnosticsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 8, 2013
Design
- Study type
- Observational
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
xTAG RPP assay is a PCR-based assay to detect the presence or absence of viral and bacterial DNA / RNA in clinical specimens (nasopharyngeal swabs). The objective of this study is to establish diagnostic accuracy of the xTAG RPP.
Conditions
- Respiratory Tract Infection
- Bronchitis
- Bronchiolitis
- Pneumonia
Interventions
xTAG RPPDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Diagnostic accuracy will be expressed in terms of clinical sensitivity and specificity for each claimed target.Time frame: Within the first year after sample extraction
Locations
4 sites in 2 countries. Site status is shown where the registry gives one.
St. Louis Children's Hospital
St Louis, Missouri
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.